
David Scott Miller MD FACOG, FACS
Gynecologic Oncology
Amy and Vernon E. Faulconer Distinguished Chair in Medical Science, Dallas Foundation Chair in Gynecologic Oncology, Professor of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas, U.S.A.
Join to view full profile
2201 Inwood Rd., #NC3.4ADallas, TX 75390
Phone+1 214-645-4673
Fax+1 214-645-2545
Dr. Miller is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Miller is former Director of Gynecologic Oncology, Professor of Obstetrics & Gynecology, and holds the Amy and Vernon E. Faulconer Distinguished Chair in Medical Science and the Dallas Foundation Chair in Gynecologic Oncology at the University of Texas Southwestern Medical Center. He serves as Medical Director of Gynecologic Oncology and Chair of the Cancer Committee for the Parkland Health and Hospital System. Among his numerous professional affiliations, he is a fellow of the American College of Obstetricians & Gynecologists and the American College of Surgeons, a member of the American Society of Clinical Oncology and Society of Gynecologic Oncology, and was President of the Western Association of Gynecologic Oncologists. He is certified by and was an examiner for the American Board of Obstetrics & Gynecology and its Division of Gynecologic Oncology. Long active in the development of clinical trials for the treatment of gynecologic cancers, he has been Study Chair for multiple national trials of the Gynecologic Oncology Group, served on the Board of Directors, and was Chair of its Uterine Corpus Committee. The National Cancer Institute’s Cancer Therapy Evaluation Program appointed him to the Gynecologic Cancer Steering Committee. He was also Chair of the Endometrial Committee for the Gynecologic Cancer InterGroup. With the merger of the cancer cooperative groups, he now serves as Deputy Group Chair for Membership and Research Integrity for NRG Oncology. He has sought to add to the body of knowledge in gynecologic oncology having authored over 200 articles and book chapters and given over 500 invited lectures.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Gynecologic Oncology, 1983 - 1985
Drexel University College of Medicine/Hahnemann University HospitalResidency, Obstetrics and Gynecology, 1977 - 1981
Drexel University College of Medicine/Hahnemann University HospitalInternship, Obstetrics and Gynecology, 1977 - 1978
University of Oklahoma College of MedicineClass of 1977
Certifications & Licensure
CA State Medical License 1981 - Present
TX State Medical License 1991 - 2027
IL State Medical License 1985 - 1993
SC State Medical License 1982 - 1983
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
Clinical Trials
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
- Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
Publications & Presentations
PubMed
- E7386 plus lenvatinib in patients with advanced endometrial cancer that progressed on platinum-based chemotherapy and an anti-PD-(L)1 immunotherapy: a single-arm, open...Jung-Yun Lee, Kosei Hasegawa, Byoung-Gie Kim, Barry Berman, Shiro Suzuki
Eclinicalmedicine. 2026-10-01 - Impact of Interruptions in Chemotherapy on Survival for Patients With Metastatic or Recurrent Cervical Cancer.Risha Sinha, Arianna Portmann-Baracco, April R Gorman, Elizabeth C Stock, Steven Blaine Holloway
American Journal of Clinical Oncology. 2026-08-01 - Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy ou...Christian Marth, Domenica Lorusso, Mariusz Bidziński, Paolo Scollo, Mehmet Ali Vardar
International Journal of Gynecological Cancer. 2026-07-01
Other
- Treatment of locally advanced, recurrent, or metastatic endometrial cancerMiller DS, Campos SM
http://www.uptodate.com/contents/treatment-of-locally-advanced-recurrent-or-metastatic-endometrial-c
UpToDate, Wolters Kluwer Health - 2013-02-25
Authored Content
- NRG Membership with Dr. David MillerJuly 2025
- Using Molecular Testing and Biomarkers to Guide Therapy in a Patient With Advanced Endometrial CarcinomaJuly 2025
- Molecular Subtypes and Biomarkers in Endometrial CancerJuly 2025
Press Mentions
Raising Ovarian Cancer AwarenessMay 7th, 2026
These Tiny Beads May Offer Big Hope to Ovarian Cancer PatientsMay 1st, 2023
Multiple lawsuits claim hair relaxer products contain chemicals that can cause uterine cancerFebruary 27th, 2023
Professional Memberships
- Member
- Fellow
- Fellow
- Society of Gynecologic OncologyMember
- Dallas County Medical SocietyMember
External Links
- University of Texas Southwestern Medical Centerhttp://www.utsouthwestern.edu/patientcare/doctor/findphysician/profile/0,0,14954_Dr_David_Miller_MD,00.html
- American College of Surgeonshttp://web2.facs.org/acsdir/public/detailmember.cfm?CHKDGTS=00300008590
- American Society of Clinical Oncologyhttp://www.asco.org/portal/site/ASCOv2/template.PAGE/member-directory/?javax.portlet.tpst=04f5ebfc0463247ad110dc104c37a01d_ws_MX&javax.portlet.prp_04f5ebfc0463247ad110dc104c37a01d_viewID=find_member_detail_view&javax.portlet.begCacheTok=com.vignette.cache
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:





